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The aim of this study was to evaluate the antifungal susceptibility of 33 Candida spp. isolates to classic 
antifungals included in Multodisc® system kits (Liofilchem – Italy). The research was conducted during 
January-June 2014 in the Department of Microbiology, Faculty of Veterinary Medicine, Cluj-Napoca, 
Romania. Identification was made from 48 hrs isolated colonies, using microscopic and biochemical 
methods (API Candida). From the total of 33 tested strains, 13 were represented by Candida albicans, 9 
strains were identified as Candida krusei, 6 were Candida tropicalis 3 Candida catenulata and 2 were 
Candida parapsilosis. The antifungals included in the disk were represented by Econazole, Nystatin, 
Griseofulvin, Amphotericin B, Flucytosine, Miconazole, Metronidazole and Ketoconazole. The susceptibility 
test principle was based on the disk diffusion test, while the interpretation was performed determining the 
inhibition area diameter. The most efficient antifungal was represented by Ketoconazole with an average of 
the inhibition area of 26.4 mm followed by Miconazole with 23.4 mm and Econazole with 22.7 mm. The least 
efficient antifungals were represented by Metronidazole, Griseofulvin and Nystatin. 
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Introduction 
Candida yeast is a commensal micro-organism normally present in the gastrointestinal tract 
and an opportunistic causative agent of infections in humans and animals. The need for 
reproducible and clinically relevant antifungal susceptibility testing has been prompted by the 
increasing number of invasive fungal infections (IFIs), the expanding use of antifungal agents, and 
the recognition of antifungal resistance as an important clinical problem (Johnson, 2008). 
In recent years, along with an increase in the incidence of candidiasis, there has been an 
important shift away from Candida albicans towards non albicans spp. The change in the 
epidemiology of Candida infections can be attributed to various factors like severe 
immunocompromised status of the host, exposure to broad spectrum antibacterial agents and 
empirical use of antimycotics. However, the clinical manifestations of infections caused by 
different non albicans Candida (NAC) spp. are usually indistinguishable from those by C. albicans 
(Deorukhkar, 2014). 
In vitro antifungal susceptibility testing is now standardized internationally and is 
becoming essential in patient management and resistance surveillance; it remains less utilized than 
antibacterial testing (Deorukhkar, 2014). 
Clearly, the disc diffusion method has the potential to provide a simple means of 
performing in vitro tests, but not all antifungal agents are available in discs. Furthermore, the discs 
are very expensive and their acquisition in developing countries is sometimes difficult (Magaldi, 
2004).  
The study was conducted on Candida isolates from animals and humans, and major 
objectives were to evaluate the antifungal susceptibility of 33 Candida spp. isolates to classic 
antifungals included in Multodisc® system kits (Liofilchem – Italy) and to recommend the best 





 Materials and methods 
The researches of this study were conducted during January-June 2014 in the Laboratory 
of Microbiology, Faculty of Veterinary Medicine in Cluj-Napoca. A total of 33 Candida specimens 
isolated from animals with different pathologies (otitis, pharyngitis, mastitis), humans, and strains 
that contaminated diverse culture media, were included in this study. Candida tested strains were 
isolated from samples of mastitic cow milk, ear discharge from dogs with otitis, throat swabs from 
human subjects tonsillitis, urine samples from women with cystitis, faecal samples from hens and 
pigeons, ruminal fluid samples from cows, various strains that contaminated the culture media, 
throat swab samples from dogs and cosmetic products.  Identification was made from 48 hrs 
isolated colonies, using microscopic and biochemical methods (API Candida). 
 Pure culture 48 hrs old well isolated yeast colonies were suspended in 5 ml of a sterile 
physiological solution until 0.5 McFarland turbidity is reached. A sterile swab was immersed in 
the suspension broth and then squeezed on the wall of the test tube to eliminate excess fluid. The 
swab was dragged along the surface of a SDA agar plate as to produce even growth. Antifungals 
included in the ring were represented by Econazole (ECN - 10µg), Nystatin (NY – 100 I.U.), 
Griseofulvin (GF - 10µg), Amphotericin B (AMB - 20µg), Flucytosine (FY - 1µg), Miconazole 
(MCL - 10µg), Metronidazole (MTZ - 10µg) and Ketoconazole (KCA - 10µg). The Multodisc® 
ring was positioned within 15 minutes from inoculation of the plates, pressing them with sterile 
pliers on the surface of the agar and then incubated at 35°C +/- 2° for 20-24 hours. 
 After incubation, the plates are examined; the inhibition halos around each disc are 
examined and compared with the standard inhibition haloes: in this way, the microorganisms are 
defined as being susceptible, intermediate or resistant to the tested antifungal agents.  
   
Results and discussions 
From the total of 33 tested strains, 13 were represented by Candida albicans, 9 strains were 
identified as Candida krusei, 6 were Candida tropicalis 3 Candida catenulata and 2 were Candida 
parapsilosis. 
 Susceptibility test principle was based on the disk diffusion test, while the interpretation 
was performed determining the inhibition area diameter. The interpretation was performed 
individually for each antifungal and yeast strain, and then the average of inhibition area was 
determined for each antifungal. Where total resistance was observed, the value considered for the 
calculation was zero. The most efficient antifungal was represented by Ketoconazole with an 
average of the inhibition area of 26.4 mm, followed by Miconazole with 23.4 mm and Econazole 
with 22.7 mm. The least efficient antifungals were represented by Metronidazole with 12.3 mm, 
Griseofulvin with 9.11 and Nystatin with 8.32 mm. 
   
 
 






Fig. 2. Susceptibility testing for strain  
23 A - Candida albicans 
Fig. 3. Susceptibility testing for strain LM 




Fig. 4. Susceptibility testing for strain  
171 S - Candida tropicalis 
Fig. 5. Susceptibility testing for strain 4 
Cand. - Candida parapsilosis 
 
The results are in agreement to the studies of Giri, 2014, that on 39 Candida isolated 
obrained resistence patterns for fluconazole, ketoconazole and amphotericin B. The disk-diffusion 
method can offer a good level of sensitivity if the technique is performed by CLSI standards. 
Comparing the results of Multodisc® test with the results of Etest, is observed that 
fluconazole is generally recommended as a therapeutic choice for systemic candidiasis, but 
amphotericin B does not have the same efficiency against Candida isolated in Cluj-Napoca 
compared to human patients with oral candidiasis (Song, 2015). 
 
 Conclusions 
The researches on identification of Candida spp. isolates from animals and humans in Cluj 





 Api Candida system is a good method, easy to use and represents a relatively quick and 
inexpensive tool for Candida specie identification. 
 C. albicans predominates in Cluj-Napoca area, followed by C. krusei, C. tropicalis, C. 
catenulata and C. parapsilosis. 
 Classic antifungals tend to be less efficient in in vitro susceptibility testing of Candida 
species, due to their frequent use, except for Ketoconazole and Miconazole. 
 The use of antifungals against Candida infections requires prior susceptibility testing in 
order to prevent antifungal resistance to these products. 
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